Description
Article no.: AS13 2719B
|
Immunogen |
Synthetic peptide derived from human Alpha-Synuclein N-terminal, amino acids 1-15. |
|
Host |
Mouse |
|
Clonality |
Monoclonal |
|
Subclass/isotype |
IgG2a |
|
Purity |
Affinity purified |
|
Format |
Lyophilized |
|
Quantity |
50 µg |
|
Reconstitution |
For reconstitution add 50 µl of sterile water. |
|
Storage |
For short time storage add sodium azide and store at +4°C. |
|
Tested applications |
ELISA (ELISA) |
|
Recommended Dilution |
2-4 ug/ml (ELISA capture) |
|
Expected | apparent MW |
14 kDa |
|
Confirmed Reactivity |
Human |
|
Not reactive in |
No confirmed exceptions from predicted reactivity are currently known. |
|
Additional information |
This antibody is biotinylated. |
|
Related products |
|
Background |
Alpha-synuclein is normally an unstructured soluble protein that can aggregate to form insoluble fibrils in pathological conditions characterized by Lewy bodies, such as Parkinson's disease, dementia with Lewy-bodies, and multiple system atrophy. In analogy to many other amyloid associated disorders, alpha-synuclein may also form oligomeric assemblies. These small and soluble forms have been suggested to exert a stronger tissue damaging effect as compared to the monomeric and fibrillar counterpart. Using a recently developed technique a monoclonal oligomer-specific antibody has been designed. |
|
Product citations |
To be added when available. |